Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
2.090
+0.010 (0.48%)
At close: Sep 26, 2025, 4:00 PM EDT
2.070
-0.020 (-0.96%)
After-hours: Sep 26, 2025, 6:45 PM EDT
Daré Bioscience Market Cap
Daré Bioscience has a market cap or net worth of $27.55 million as of September 26, 2025. Its market cap has decreased by -1.27% in one year.
Market Cap
27.55M
Enterprise Value
25.54M
1-Year Change
-1.27%
Ranking
Category
Stock Price
$2.09
Market Cap Chart
Since April 10, 2014, Daré Bioscience's market cap has decreased from $98.00M to $27.55M, a decrease of -71.89%. That is a compound annual growth rate of -10.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 28.20M | 4.06% |
| Dec 31, 2024 | 27.10M | -11.15% |
| Dec 29, 2023 | 30.50M | -56.68% |
| Dec 30, 2022 | 70.40M | -54.05% |
| Dec 31, 2021 | 153.20M | 200.98% |
| Dec 31, 2020 | 50.90M | 271.53% |
| Dec 31, 2019 | 13.70M | 69.14% |
| Dec 31, 2018 | 8.10M | -38.17% |
| Dec 29, 2017 | 13.10M | -32.47% |
| Dec 30, 2016 | 19.40M | -74.67% |
| Dec 31, 2015 | 76.60M | -38.82% |
| Dec 31, 2014 | 125.20M | 27.76% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 650.45B |
| Johnson & Johnson | 432.80B |
| AbbVie | 389.72B |
| UnitedHealth Group | 311.62B |
| Novo Nordisk | 242.68B |
| Novartis AG | 238.65B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 228.75B |